DEXCOM INC's ticker is and the CUSIP is 252131AH0. A total of 19 filers reported holding DEXCOM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,819,000 | -60.5% | 920,000 | -34.7% | 0.05% | -44.1% |
| Q4 2021 | $4,601,000 | -16.6% | 1,409,000 | -15.1% | 0.09% | -22.5% |
| Q3 2021 | $5,518,000 | -20.3% | 1,659,000 | -37.6% | 0.12% | -23.1% |
| Q2 2021 | $6,923,000 | +11.3% | 2,659,000 | -5.1% | 0.16% | +6.8% |
| Q1 2021 | $6,218,000 | -2.6% | 2,801,000 | 0.0% | 0.15% | -10.4% |
| Q4 2020 | $6,384,000 | -10.1% | 2,801,000 | 0.0% | 0.16% | -22.7% |
| Q3 2020 | $7,105,000 | -4.7% | 2,801,000 | -6.6% | 0.21% | -11.0% |
| Q2 2020 | $7,454,000 | -14.1% | 3,000,000 | -40.0% | 0.24% | -22.8% |
| Q1 2020 | $8,675,000 | +17.1% | 5,000,000 | 0.0% | 0.31% | +46.2% |
| Q4 2019 | $7,409,000 | – | 5,000,000 | – | 0.21% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Elequin Capital, LP | 11,771,000 | $26,632,270 | 5.17% |
| Calamos Advisors LLC | 30,006,000 | $67,881,974 | 0.35% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 5,000,000 | $11,302,500 | 0.05% |
| D. E. Shaw & Co., Inc. | 10,000,000 | $23,351,070 | 0.02% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 23,000,000 | $52,692,310 | 0.02% |
| BNP PARIBAS FINANCIAL MARKETS | 1,035,000 | $2,337,030 | 0.00% |
| LOOMIS SAYLES & CO L P | 9,739 | $909 | 0.00% |
| MORGAN STANLEY | 2,500,000 | $5,648,750 | 0.00% |
| FMR LLC | 6,019,000 | $13,590,902 | 0.00% |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 200,000 | $451,600 | 0.00% |